Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARINA-1 in NCFBE
NCT05495243Phase 2Completed
- Sponsor
- Renovion
- Start
- Oct 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFB), sponsored by Renovion. Started Oct 2022; status: completed.
02
Drugs
ARINA-1
03
Conditions
Non-Cystic Fibrosis Bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT05495243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05495243.